Alzheimer's Research Studies

The Synaptic Therapy Alzheimer's Research Trial (START) is a national study funded by the National Institute on Aging (NIA) of the National Institutes of Health (NIH). It is conducted by a network of Alzheimer's disease investigators sponsored by Cognition Therapeutics, coordinated by the University of Southern California’s Alzheimer’s Therapeutic Research Institute (ATRI) and in collaboration with the Alzheimer’s Clinical Trials Consortium (ACTC).

White matter hyperintensities (WMHs) are bright patches that can only be see when pictures of the brain are taken through an MRI scan. WMHs are usually found in people with Alzheimer’s disease and related disorders.

UW researchers are investigating why white matter hyperintensities occur by analyzing blood biomarkers, cerebrospinal fluid, cognitive testing, and magnetic resonance imaging (MRI).

White matter hyperintensities (WMHs) are bright patches that can only be see when pictures of the brain are taken through an MRI scan. WMHs are usually found in people with Alzheimer’s disease and related disorders.

UW researchers are investigating why white matter hyperintensities occur by analyzing blood biomarkers, cerebrospinal fluid, cognitive testing, and magnetic resonance imaging (MRI).

The Women’s Health & Cognition Study is enrolling women age 35 and older who may have a higher risk of developing Alzheimer’s disease later in life. This study explores the relationship between hormone declines with menopause and brain changes contributing to cognition in aging females. Women across all reproductive stages are welcome to participate, though there is a special interest in those who are actively going through menopause. Men age 55+ are also invited to this study to serve as healthy control subjects.